Department of Dermatology, Venereology and Allergology, Experimental Dermatology, Medical Faculty Mannheim, Heidelberg Ruprecht-Karls-University, Mannheim, Germany.
Br J Dermatol. 2010 Aug;163(2):420-3. doi: 10.1111/j.1365-2133.2010.09759.x. Epub 2010 Mar 10.
There exists no treatment of choice for follicular mucinosis (FM). Historically two distinct entities of FM have been proposed: FM of children and young adults not associated with other diseases ('idiopathic' FM), and FM in elderly patients associated with mycosis fungoides and Sézary syndrome ('lymphoma-associated' FM). Nowadays it is suggested that 'idiopathic' FM might represent a localized form of cutaneous T-cell lymphoma. Six patients with 'idiopathic' FM were treated with hydroxychloroquine (HCQ) at a dose of 200 mg three times daily for 10 days followed by a dose adjusted to the ideal body weight, usually 200 mg twice daily. All patients showed an improvement of 'idiopathic' FM already after 6 weeks and a complete remission with full hair regrowth after 2-5 months of HCQ therapy. In all patients no relapse occurred during follow up of between 3 and 23 years and no patient developed lymphoma. We conclude that HCQ is a highly effective therapy without significant side-effects in the treatment of so-called 'idiopathic' FM.
目前,滤泡黏蛋白病(FM)尚无标准治疗方法。从历史上看,FM 可分为两类:一类为儿童和青年患者,不伴其他疾病(“特发性”FM);另一类为老年患者,与蕈样真菌病和 Sezary 综合征相关(“淋巴瘤相关”FM)。目前认为,“特发性”FM 可能是皮肤 T 细胞淋巴瘤的局部表现。我们对 6 例“特发性”FM 患者采用羟氯喹(HCQ)治疗,剂量为 200mg,每日 3 次,共 10 天,之后根据理想体重调整剂量,通常为 200mg,每日 2 次。所有患者在 HCQ 治疗 6 周后即出现 FM 改善,2-5 个月后完全缓解并出现毛发再生。所有患者在 3 至 23 年的随访中均未复发,也无一例患者发展为淋巴瘤。我们的结论是,HCQ 是一种治疗“特发性”FM 的有效方法,副作用小。